Effects of Escalating Doses of Sildenafil on Hemodynamics and Gas Exchange in Children With Pulmonary Hypertension and Congenital Cardiac Defects

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 21, Issue 2, 2007, Pages 203-207

  Raja, Shahzad G ^a   Danton, Mark D ^a   MacArthur, Kenneth J ^a   Pollock, James C ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

congenital cardiac defects; nitric oxide; pediatric pulmonary hypertension; sildenafil

Indexed keywords

NITRIC OXIDE; SILDENAFIL;

ARTERIAL GAS; ARTERIAL OXYGEN TENSION; ARTICLE; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGENITAL HEART MALFORMATION; DRUG DOSE ESCALATION; EXTUBATION; FEMALE; GAS EXCHANGE; HEART HEMODYNAMICS; HUMAN; INFANT; INTENSIVE CARE; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; TERTIARY HEALTH CARE;

ANALYSIS OF VARIANCE; BLOOD GAS ANALYSIS; BRONCHODILATOR AGENTS; CARDIAC SURGICAL PROCEDURES; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GREAT BRITAIN; HEART DEFECTS, CONGENITAL; HEART RATE; HUMANS; HYPERTENSION, PULMONARY; MALE; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PROSPECTIVE STUDIES; PULMONARY GAS EXCHANGE; PULMONARY WEDGE PRESSURE; PURINES; RESEARCH DESIGN; SULFONES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 34047188634     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2006.02.010     Document Type: Article

References (27)

1. Ravishankar C., Tabbutt S., and Wernovsky G. Critical care in cardiovascular medicine. Curr Opin Pediatr 15 (2003) 443-453
2. Michelakis E.D., Tymchak W., Noga M., et al. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation 108 (2003) 2066-2099
3. Bhatia S., Frantz R.P., Severson C.J., et al. Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy. Mayo Clin Proc 78 (2003) 1207-1213
4. Stocker C., Penny D.J., Brizard C.P., et al. Intravenous sildenafil and inhaled nitric oxide: A randomised trial in infants after cardiac surgery. Intensive Care Med 29 (2003) 1996-2003
5. Schulze-Neick I., Hartenstein P., Li J., et al. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Circulation 108 suppl 1 (2003) II167-II173
6. Ghofrani H.A., Olschewski H., Seeger W., et al. Sildenafil for treatment of severe pulmonary hypertension and commencing right-heart failure. Pneumologie 56 (2002) 665-672
7. Kothari S.S., and Duggal B. Chronic oral sildenafil therapy in severe pulmonary artery hypertension. Indian Heart J 54 (2002) 404-409
8. Reffelmann T., and Kloner R.A. Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease. Circulation 108 (2003) 239-244
9. Prasad S., Wilkinson J., and Gatzoulis M.A. Sildenafil in primary pulmonary hypertension. N Engl J Med 343 (2000) 1342-1343
10. Abrams D., Schulze-Nieck I., and Magee A.G. Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Heart 84 (2000) e4-e5
11. Zhao L., Mason N.A., and Morrell N.W. Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation 104 (2001) 424-428
12. Atz A.M., Lefler A.K., Fairbrother D.L., et al. Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises. J Thorac Cardiovasc Surg 124 (2002) 628-629
13. Atz A.M., and Wessel D.L. Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 91 (1999) 307-310
14. Yock P.G., and Popp R.L. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 70 (1984) 657-662
15. Krenzelok E.P. Sildenafil: Clinical toxicology profile. J Toxicol Clin Toxicol 38 (2000) 645-651
16. Miller O.I., Tang S.F., Keech A., et al. Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: A randomized double-blind study. Lancet 356 (2000) 1464-1469
17. Lorts A., Pearl J.M., and Shanley T.P. Bouncing back from inhaled nitric oxide. Pediatr Crit Care Med 5 (2004) 294-295
18. Laquay N., Levy M.L., Vaccaroni L., et al. Use of oral sildenafil (Viagra) in pulmonary hypertension after cardiac pediatric surgery. Ann Fr Anesth Reanim 22 (2003) 140-143
19. Raja S.G., and Nayak S.H. Sildenafil: Emerging cardiovascular indications. Ann Thorac Surg 78 (2004) 1496-1506
20. Carroll W.D., and Dhillon R. Sildenafil as a treatment for pulmonary hypertension. Arch Dis Child 88 (2003) 827-828
21. Abrams D., Schulze-Neick I., and Magee A.G. Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Heart 84 (2000) E4
22. Glossmann H., Petrischor G., and Bartsch G. Molecular mechanisms of the effects of sildenafil (VIAGRA). Exp Gerontol 34 (1999) 305-318
23. Kleinsasser A., Loeckinger A., Hoermann C., et al. Sildenafil modulates hemodynamics and pulmonary gas exchange. Am J Respir Crit Care Med 163 (2001) 339-343
24. Lee A.J., Chiao T.B., and Tsang M.P. Sildenafil for pulmonary hypertension. Ann Pharmacother 39 (2005) 869-884
25. Chai P.J., Williamson J.A., Lodge A.J., et al. Effects of ischemia on pulmonary dysfunction after cardiopulmonary bypass. Ann Thorac Surg 67 (1999) 731-735
26. Lindberg L., Olsson A.K., Jogi P., et al. How common is severe pulmonary hypertension after pediatric cardiac surgery?. J Thorac Cardiovasc Surg 123 (2002) 1155-1163
27. Raja S.G. Milrinone for pulmonary hypertension: Additional benefits, concerns, and caution. J Cardiothorac Vasc Anesth 19 (2005) 134-135